Research in action: Dr. Laura Rosella
Research in Action
12 Jan 2017
Estimating diabetes population risk to inform community reduction strategies
The rate of people with Type 2 diabetes is growing at an alarming pace in Canada. According to the Canadian Diabetes Association, 2.7 million Canadians have diabetes and this is expected to rise to 4.2 million by 2020. PHO’s Dr. Laura Rosella is investigating ways to address this critical issue from a broad population health perspective. Rosella has developed tools that calculate the risk of diabetes in a given population, to help decision-makers and program planners create and implement diabetes reduction strategies in their communities.
Absolute risk reduction in 10-year diabetes risk) as a result of (A) 5% weight reduction and (B) a lifestyle intervention for different target populations
(Rosella L.C., Lebenbaum, M. Estimating Population Benefits Using a Risk Tool: An Example of Diabetes in Canada. Annals of Epidemiology 2012; 22(9):667.)
Rosella points out that decision-makers typically go to the literature or do an evidence synthesis to inform their local diabetes prevention strategies. DPoRT aims to do more: “It is about fitting in a different way of thinking — not just what intervention works, but how many people are at risk? Who are they and why is this relevant to my community?” says Rosella.
As Rosella notes, the interventions found in the literature rarely consider the distribution of the population. Rather, they focus on the interventions themselves — what works and what does not. DPoRT assists in determining which interventions will have the greatest impact to their communities.
DPoRT also allows decision-makers to evaluate the impact of different scenarios. “What if we targeted this population with this level of intervention, which we know about from the literature? What impact will this have versus another approach? There are numerous diabetes strategies, so we run numbers in terms of expected interventions and cases, thinking about how many people need to be screened or targeted to get impact,” says Rosella. “The decision-makers provide the critical local context and input to determine what interventions are feasible and might succeed.”
DPoRT was developed and validated with local public health partners in Ontario. Peel Public Health participated in a very successful pilot, and Peel’s epidemiologists are now using it to inform delivery of services such as prevention programs.
“In planning programs and policies aimed at reducing the prevalence of chronic diseases in the total population, public health decision-makers have hitherto had to rely on data generated in clinical settings, on high-risk populations,” said Dr. David Mowat, medical officer of health, Peel Region. “The advent of DPoRT enables us to understand risk within the entire population and to plan the most effective approaches to prevention for everyone.”
Rosella has received a Canadian Institutes of Health Research grant to further disseminate and implement the tool in health units in Ontario and in other jurisdictions in Canada. Her research is now focusing on the implementation of DPoRT. To do so, she’s been consulting with decision-makers in multiple Canadian provinces and jurisdictions and is continuing to adapt the tool based on user feedback.
User feedback continues to drive enhancements to DPoRT. For example, the original design predicted incidence (i.e. new cases in a given time period). However, decision-makers also wanted to understand the financial impact of those potential new cases. Rosella is now integrating estimates of attributable costs into the tools, adding new capabilities that enhance the measurement of population risk. “In this climate, this fiscal component needs to be in every conversation,” says Rosella.
Ten-year estimate of diabetes risk, % (diamonds) and number of incident cases in thousands (bars) according to baseline HbA1c and Fasting Plasma Glucose (FPG), in the Canadian Health Measures Survey collected 2007 to 2011
(Rosella L.C. 1, Rivera L, Lebenbaum M. Implications of Clinical Targets for Diabetes Prevention. Annals of Epidemiology 2013; 23(9):587-588.)
Decision-makers also wanted to know prevalence. “In terms of burden, it’s not just how many people are currently living with diabetes, but what new cases — the focus for prevention — are predicted. Decision-makers need the full picture — existing plus new cases — to get a total number and understand the burden,” says Rosella. “DPoRT puts this information in the hands of the people who need it to plan, prioritize, and develop a course of action.”
Rosella’s published research on DPoRT and its use can be found at:
- Risk distribution and its influence on the population targets for diabetes prevention. Rosella L, Lenenbaum M, Li Y, Wang J, Manuel D. Preventative Medicine. October 2013. http://www.sciencedirect.com/science/article/pii/S0091743513003770
- The role of ethnicity in predicting diabetes risk at the population level. Rosella LC, Mustard C, Stukel TA, Corey P, Hux J, Roos L, Manuel DG. Ethn Health. January 2012. http://www.ncbi.nlm.nih.gov/pubmed/22292745
- A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). Rosella LC, Manuel DG, Burchill C, Stukel TA; PHIAT-DM team. J Epidemiol Community Health. July 2011. http://www.ncbi.nlm.nih.gov/pubmed/20515896
- How many Canadians will be diagnosed with diabetes between 2007 and 2017? Assessing population risk. ICES Investigative Report. Manuel DG, Rosella LCA, Tuna M, Bennett C. Institute for Clinical Evaluative Sciences. 2010. http://www.ices.on.ca/file/Diabetes%20Risks%20June%2016%202010.pdf